DEV ENVIRONMENT — dev.library.globalcastmd.com — Changes here do not affect production
0 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

The Bethesda System for Reporting Thyroid Cytopathology: Risk of Malignancy in Pediatric Thyroid Nodules

Published: Reading: 1 min

Topic overview

This study evaluates malignancy risk across Bethesda System categories specifically in pediatric thyroid nodules, comparing institutional data with the 2023 TBSRTC pediatric guidelines. The research addresses the critical need for age-specific risk stratification, given that children have higher malignancy rates than adults despite lower nodule prevalence.

Key takeaways

  • Thyroid nodules are rare in children but carry higher malignancy rates than in adults.
  • The Bethesda System (TBSRTC) standardizes thyroid FNA reporting and risk stratification globally.
  • The 2023 TBSRTC update now includes pediatric-specific risk of malignancy predictions and management guidance.
  • This study validates Bethesda category risk of malignancy in a pediatric cohort against 2023 guidelines.

Keywords

Thyroid Cytopathology Pediatric Thyroid Nodules Bethesda System Fine Needle Aspiration Malignancy Risk Stratification Pediatric Endocrinology

Hashtags

#ThyroidCytopathology #PediatricEndocrinology #BethesdaSystem #ThyroidFNA

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. The Bethesda System for Reporting Thyroid Cytopathology: Risk of Malignancy in Pediatric Thyroid Nodules. GlobalCastMD Medical Library. 2024-12-27. https://dev.library.globalcastmd.com/article/9576?via_space=staycurrentmd

Comments

Loading comments...